Improvement of molecular monitoring of residual disease in leukemias by bedside RNA stabilization.
Müller MC, Merx K, Weisser A, Kreil S, Lahaye T, Hehlmann R, Hochhaus A
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine if a room temperature delay of 72 h prior to processing of peripheral blood specimens impacts the expression of therapy efficacy genetic markers, and whether a novel RNA stabilization system can attenuate potential effects.
Summary of Findings
Expression ratios were poorly correlated in unstabilized controls when specimens stored for 2 h and 72 h at room temperature were compared (r=0.65-0.75), indicating a notable effect of storage duration on gene expression; effects were partially attenuated in PAXgene Blood RNA stabilized specimens, generating strong correlations among specimens stored for 2 h and 72 h prior to processing (r=0.95-0.99). Of note, gene expression was significantly higher in specimens extracted using the PAXgene Blood RNA kit compared to RNAeasy Mini Kit processed controls, preventing a direct comparison of stabilization and analyte extraction methods. The sensitivity of the PAXgene Blood RNA stabilization method was comparable to CsCl gradient ultra centrifugation.
Biospecimens
FluidBloodPreservation Types
None (Fresh)PAXgeneDiagnoses
NeoplasticLeukemiaPlatforms
RNAReal-time qRT-PCRPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Type of collection container/solution EDTA VacutainerPAXgene tubeBiospecimen Preservation Type of fixation/preservation None (fresh)PAXgeneStorage Time at room temperature 2 h72 hAnalyte Extraction and Purification Analyte isolation method PAXgene Blood RNA KitRNeasy Mini KitReal-time qRT-PCR Specific Targeted nucleic acid BCR-ABLG6PDTotal ABL